Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
Patent Number: 6255112
Date of First Priority Issue: Monday June 8th, 1998
Date Issued: Tuesday July 3rd, 2001
Assignee: Osiris Therapeutics, Inc. (Baltimore, MD)
Inventors: Thiede, Mark A. (Forest Hill, MD); Mbalaviele, Gabriel (Columbia, MD)
From Class: Differentiation
Comments: No comments
This patent covers the use of mesenchymal stem cells to stimulate hematopoietic stem cells. Mesenchymal stem cells are actually in Phase III trials for prevention of graft versus host after hematopoietic stem cell transplants. This patent ensures that if the mesenchymal stem cells also stimulate hematopoiesis, then Osiris is covered from an IP perspective.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.